Neurovascular Devices Market

The report "Neurovascular Devices Market by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030", is projected to reach USD 7.22 billion in 2030 from USD 4.64 billion in 2025, at a CAGR of 9.3% during the forecast period.

Browse 150 market data Tables and 70 Figures spread through 300 Pages and in-depth TOC on "Neurovascular Devices Market by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html

The global neurovascular devices market is expected to grow during the forecast period due to the increasing incidence of neurovascular diseases, such as stroke, brain aneurysms, and arteriovenous malformations, which are significantly driving the demand for advanced diagnostic and treatment solutions. Simultaneously, the expansion of healthcare infrastructure in emerging economies is facilitating wider adoption of neurointerventional technologies, closing gaps in specialized care.

Based on disease pathology, the cerebral aneurysm segment is expected to account for the largest share of the global neurovascular devices market.

Based on disease pathology, the global neurovascular devices market is divided into five main segments: cerebral aneurysms, ischemic strokes, carotid artery stenosis, arteriovenous malformations and fistulas, and other disease pathologies.

The high incidence of cerebral aneurysms results from a combination of genetic, physiological, and lifestyle factors. People with a family history or certain genetic disorders are more vulnerable, while chronic hypertension, smoking, and atherosclerosis further weaken blood vessel walls. Age and gender also influence risk, with middle-aged adults and women being more susceptible. Additionally, lifestyle choices like alcohol abuse and sedentary behaviors add to vascular stress, collectively increasing the likelihood of aneurysm formation.

Based on end user,  the hospitals and ambulatory surgical centers segment is expected to account for the largest share of the global neurovascular devices market.

Based on end user, the global neurovascular devices market is segmented by end user into the following categories: hospitals & ambulatory surgical centers, specialty clinics, research and academic institutes.

Among these, the hospitals & ambulatory surgical centers segment is expected to hold the largest market share because they provide the necessary infrastructure, specialized equipment, and trained personnel needed for complex neurovascular procedures. These facilities can manage high-risk cases such as strokes, cerebral aneurysms, and arteriovenous malformations, which often require immediate intervention. Advanced imaging technologies, operating rooms designed for minimally invasive surgeries, and multidisciplinary teams make hospitals and surgical centers the preferred settings for neurovascular treatments. Additionally, their ability to handle post-operative care and emergencies further strengthens their dominant role in the market.

North America is expected to dominate the neurovascular devices market during the forecast period.

The global market for neurovascular devices is divided into six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries.

North America leads the neurovascular devices market, supported by a robust healthcare infrastructure and high consumer demand for neurovascular devices. The region has a well-developed healthcare system with widespread access to advanced hospitals, specialized surgical centers, and skilled neurosurgeons. The high prevalence of neurological conditions such as stroke, cerebral aneurysms, and other vascular disorders fuels strong demand for neurovascular devices. Additionally, North America is an early adopter of innovative technologies, including minimally invasive devices, AI-assisted imaging, and robot-guided procedures, which enhance the use of advanced neurovascular solutions. Supportive government healthcare policies, insurance coverage, and high patient awareness also contribute to the region’s dominant market position.

Key players

Prominent players in the neurovascular devices market include Stryker (US), Medtronic (Ireland), Johnson & Johnson (US), Terumo Corporation (Japan), Penumbra (US), MicroPort Scientific Corporation (China), Balt Group (France), Kaneka Corporation (Japan), and Phenox GmbH (Wallaby Medical). Among other developments, these companies adopted strategies such as partnerships, collaborations, agreements, integrations, acquisitions, product launches, and expansions to strengthen their presence in the neurovascular devices market.

Don’t miss out on business opportunities in Neurovascular Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/